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Abstract: The serine-threonine protein kinase encoded by US3 gene (pUS3) of alphaherpesviruses
was shown to modulate actin reorganization, cell-to-cell spread, and virus egress in a number of virus
species. However, the role of the US3 orthologues of equine herpesvirus type 1 and 4 (EHV-1 and
EHV-4) has not yet been studied. Here, we show that US3 is not essential for virus replication in vitro.
However, growth rates and plaque diameters of a US3-deleted EHV-1 and a mutant in which the
catalytic active site was destroyed were significantly reduced when compared with parental and
revertant viruses or a virus in which EHV-1 US3 was replaced with the corresponding EHV-4 gene.
The reduced plaque sizes were consistent with accumulation of primarily enveloped virions in the
perinuclear space of the US3-negative EHV-1, a phenotype that was also rescued by the EHV-4
orthologue. Furthermore, actin stress fiber disassembly was significantly more pronounced in cells
infected with parental EHV-1, revertant, or the recombinant EHV-1 expressing EHV-4 US3. Finally,
we observed that deletion of US3 in EHV-1 did not affect the expression of adhesion molecules on the
surface of infected cells.
Keywords: US3; actin cytoskeleton; EHV-1; EHV-4; adhesion molecules; EM
1. Introduction
The US3 protein (pUS3) is a unique and multifunctional serine/threonine protein kinase, which is
conserved among all alphaherpesviruses, including equine herpesvirus type 1 and type 4 (EHV-1 and
EHV-4) [1–3]. Both EHV-1 and EHV-4 encode for US3 genes that have a similarity of 81.3% [4]. It has
been reported that pUS3 plays a role in the reorganization of the actin cytoskeleton, promotes nuclear
egress of newly assembled nucleocapsids through the nuclear membrane, phosphorylates different
viral and cellular protein substrates, modulates the host immune response, and protects infected
cells from apoptosis [5–7]. During infection, several alphaherpesviruses, including herpes simplex
virus type 1 and type 2 (HSV-1 and HSV-2), varicella zoster virus (VZV), pseudorabies virus (PRV),
bovine herpesvirus type 1 (BHV-1), and Marek’s disease virus (MDV) modulate the actin cytoskeleton
at almost every step of virus replication, from entry to egress and direct cell-to-cell spread. These
events are dependent mostly on the kinase activity of pUS3 [6,8–10]. For PRV, group A p21-activated
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kinases (PAKs) were found to be involved in the pUS3-induced modulation of the actin cytoskeleton and
the migration of virus particles through cell projections, ultimately leading to infection of neighboring
cells [11]. However, PAKs were shown to play a limited role in the anti-apoptotic activity of PRV US3 [12].
EHV-1 and EHV-4 are members of the genus Varicellovirus in the Alphaherpesvirinae subfamily [13,14].
Although closely related as reflected by extensive similarity of the amino acid sequences of the encoded
proteins (55–96%), their pathogenic potential differs significantly [15]. Both viruses have the same
initial site of entry, replicate initially in mucosal epithelial cells of the upper respiratory tract, and cause
respiratory disease. Only EHV-1, however, can efficiently infect the cells of lymphoid tissues, peripheral
blood mononuclear cells (PBMC), and endothelial cells (EC) of blood vessels in the central nervous
system and pregnant uterus [14]. In contrast to EHV-1 infection, almost all infections with EHV-4 do
not progress beyond the respiratory epithelia. The answer to the question of why these two viruses
have such different replication properties in vivo despite their close relatedness must be related to
differences in functions exerted by different viral proteins, possibly including pUS3. Recently, we
showed that EHV-1 deleted for the US3 gene lost its ability to transfer from infected PBMC to EC [16],
but we still do not know the exact mechanism.
After herpesvirus entry and genome replication, nucleocapsids are assembled in the nucleus.
Then, newly formed nucleocapsids egress from the nucleus by first budding at the inner leaflet of
the nuclear membrane, where they acquire the first envelope. The primarily enveloped viruses fuse
to the outer leaflet of the nuclear membrane and are released into the cytoplasm [17]. pUS3 of PRV
and HSV-1 appear to have a role during this process as deletion of the US3 gene resulted in the
accumulation of virus particles in the perinuclear space and significantly reduced virus titers [18–20].
It has been shown that pUS3 is necessary for the homogenous distribution of the primary tegument
and envelope proteins, pUL31 and pUL34, along the nuclear membrane, a process that is mediated by
phosphorylation of both proteins [7,21].
In this report, we aimed to study the role of pUS3 in EHV-1 replication, cell-to-cell spread,
and reorganization of actin cytoskeleton in host cells. We further investigated the role of pUS3 on
virus egress from the nucleus. For this purpose, we constructed EHV-1-mutants with a point mutation
targeting the catalytic activity site (EHV-1D207A) conserved among alphaherpesviruses [6], a deletion
of the US3 gene (EHV-1∆US3) and a recombinant EHV-1 harboring the EHV-4 US3 gene in lieu of
EHV-1 US3 (EHV-1-US3_4).
2. Materials and Methods
2.1. Viruses and Cells
Infectious bacterial artificial chromosome (BAC) clones of EHV-1 strain Ab4 [22] and EHV-4
strain TH20p [23] were used in this study. Both BAC clones contain the green fluorescent protein
(GFP) gene under the control of a cytomegalovirus (CMV) promoter, facilitating GFP expression in
infected cells. Viruses were grown and titrated on equine dermal (ED) cells propagated in Iscove’s
modified Dulbecco’s medium (IMDM, Invitrogen, Darmstadt, Germany) supplemented with 10% fetal
bovine serum (FBS, Biochrom, Berlin, Germany), 100 U/mL penicillin, and 100 µg/mL streptomycin.
Equine PBMC were isolated from heparinized blood collected from healthy horses by Biocoll-density
gradient separation (Biochrom AG, Berlin, Germany), following the manufacturer’s instructions.
After two washing steps, cells were suspended in Roswell Park Memorial Institute (RPMI) 1640
(Biochrom, Berlin, Germany) supplemented with 10% FBS, 0.3 mg/mL glutamine, nonessential amino
acids, and 1% penicillin-streptomycin. Blood collection was done with a permit from the Landesamt
für Gesundheit und Sociales, Berlin, Germany (L 0294/13).
For the reconstitution of mutant and recombinant viruses, EHV-1-BAC DNA was transfected into
human embryonic kidney (293T) cells using polyethylenimine (PEI, Polyscience, Niles, IL, USA) [24,25].
Three days later, ED cells were infected with supernatants from transfections.
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2.2. Plasmids
The complete EHV-1 and EHV-4 US3 genes were cloned into pcDNA3 (Invitrogen). US3 genes of
EHV-1 and EHV-4 were amplified by polymerase chain reaction (PCR) using primers P1–P4 (Table 1).
After purification, the PCR products were digested with the appropriate restriction enzymes and
inserted into pcDNA3, generating pcDNA3-US3_1 and pcDNA3-US3_4. The kanamycin-resistance
(kanR) gene was amplified from the pEPkan-S plasmid by PCR using primers P5 and P6 (Table 1),
digested with BamHI (New England Biolabs, Ipswich, MA, USA), and cloned into pcDNA3-US3_4 to
generate pcDNA3-US3_4kan. Correct amplification and cloning were confirmed by Sanger sequencing
(LGC Genomics, Berlin, Germany).
Table 1. Oligonucleotide primers used in this study.
No Primer Sequence
P1 US3 1 Hind For attaagcttatggaaaataaacaatgcga
P2 US3 1 EcoR Rev attgaattcctaaagttgtgcaaacattg
P3 US3 4 Hind For attaagcttatggaaaataaacaatacga
P4 US3 4 EcoR Rev attgaattcctacagattcataaacattg
P5 US3 4 kan ins For gattctagaggggctgcggtaccttcacgaggatgacgacgataagtaggg
P6 US3 4 kan ins Rev ccctctagaatctgtcgttctataatcaacaaccaattaaccaattctgattag
P7 US3 1 del For aagccctatagctttataggcacacgcccacggcatcggagatgactaacctgtttctggaggatgacgacgataagtaggg
P8 US3 1 del Rev gtcgcccacgctgtctcctcccagaaacaggttagtcatctccgatgccgtgggcgtgtgcaaccaattaaccaattctgattag
P9 US3 4 ins into 1 For gccgtgcgccaagccctatagctttataggcacacgcccacggcatcggaatggaaaataaacaatacga
P10 US3 4 ins into 1 Rev tttatacaccgtcgcccacgctgtctcctcccagaaacaggttagtcatcctacagattcataaacattg
P11 US3D207A For tacctgcacgcacagaggatcatccacagagcggtcaagactgaaaatattttcataaacaggatgacgacgataagtaggg
P12 US3D207A Rev gtttatgaaaatattttcagtcttgaccgctctgtggatgatcctctgtgcgtgcaggtacaaccaattaaccaattctgattag
P13 US3A207D For tacctgcacgcacagaggatcatccacagagacgtcaagactgaaaatattttcataaacaggatgacgacgataagtaggg
P14 US3A207D Rev gtttatgaaaatattttcagtcttgacgtctctgtggatgatcctctgtgcgtgcaggtacaaccaattaaccaattctgattag
P15 US3 1 Pre For ccaactccataaatttcagc
P16 US3 1 Post Rev ttacagttggtggcactgta
2.3. Mutagenesis
Deletion of the whole EHV-1-US3 gene with the subsequent generation of recombinant EHV-1
harboring US3_4 was done by en passant mutagenesis as described before [26]. Briefly, the kanR gene
was amplified by PCR using primers P7 and P8 (Table 1). After purification, the kanR amplicon was
digested with DpnI (New England Biolabs) and transformed into GS1783 cells containing EHV-1 BACs
by electroporation. Kanamycin-resistant colonies were purified and screened by PCR and restriction
fragment length polymorphism (RFLP) analyses to identify mutant clones. Positive clones were
subjected to a second Red recombination to obtain the final construct, EHV-1∆US3, after removal of
the kanR gene.
The US3_4kan transfer fragment was amplified from the pcDNA3-US3_4kan vector using
primers P9 and P10 (Table 1), digested with DpnI, electroporated into GS1783 harboring EHV-1∆US3,
and cultured on lysogeny broth (LB) agar with chloramphenicol and kanamycin. Positive clones were
isolated and confirmed by PCR and RFLP. Positive recombinant clones were selected and the kanR
gene was excised as shown above.
A point mutation targeting the US3-catalytic active site was engineered by changing the
aspartic acid into alanine (US3D207A) also by employing two-step Red-mediated recombination.
Primers P11–P14 used for mutant (US3D207A) and revertant (US3A207D) are listed in Table 1.
The respective genotypes of mutants and revertants were confirmed by PCR, RFLP, and nucleotide
sequencing using primers P15 and P16 (Table 1).
Finally, purified BAC DNA was transfected into 293T cells using PEI. EHV-1 recombinant (mutant)
and revertant viruses were further grown on ED cells and stored at −80 ◦C [27].
2.4. Western Blotting
ED cells were infected with different viruses at a multiplicity of infection (MOI) of 1. After 24 h,
cell lysates were prepared using radioimmuno-precipitation assay buffer [27]. After lysis, samples
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were resuspended in loading buffer and heated for 5 min at 95 ◦C [27]. Proteins were separated by
12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Expression of pUS3
was detected with anti-pUS3 polyclonal antibodies, kindly provided by Dr. Dennis J. O’Callaghan
(Louisiana State University Health Sciences Center, Shreveport, LA, USA) [28]. As a control for virus
infection, cell lysates were blotted and stained with EHV-1 anti-gB small subunit 12D12 monoclonal
antibodies (mAb) [29], kindly provided by Dr. Udeni B. R. Balasuriya (Gluck Equine Research Center,
University of Kentucky, Lexington, KY, USA). Goat anti-rabbit and anti-mouse labelled with horse
radish peroxidase (HRP) were diluted at 1:10,000 in skimmed milk and used as secondary antibodies.
Reactive protein bands were visualized by enhanced chemoluminescence (ECL Plus; Amersham,
GE Healthcare, Piscataway, NJ, USA).
2.5. Virus Growth Assay
To determine virus replication, single-step growth kinetics and plaque diameters were determined
as described before [27]. Briefly, confluent ED cells were infected at an MOI of 1 (in the case of
EHV-1, EHV-1∆US3, and EHV-1US3_4) or 0.1 (in the case of EHV-1, EHV-1D207A, and EHV-1A207D)
and incubated for 1 h at 37 ◦C. Cells were washed with PBS, treated with citrate buffer (pH = 3),
and supplemented with fresh medium. Supernatant and infected cells were collected separately at the
indicated time points and stored at −20 ◦C. Growth kinetics were determined in three independent
experiments. For plaque size assays, ED cells were infected with viruses at an MOI of 0.001. After 1 h
of incubation, an overlay was added of IMDM containing 0.5% methylcellulose (Sigma, Darmstadt,
Germany) and incubated for 72 h. In three independent experiments, 50 GFP-expressing plaques were
photographed for each virus and average plaque diameters were measured using ImageJ software
(vl.32j, National Institutes of Health, Bethesda, MD, USA, 2004) [27]. Values were calculated and
compared to plaque diameters of parental viruses, which were set to 100%.
2.6. Labeling of the Actin Cytoskeleton
ED cells were grown on glass coverslips in a 24-well plate and infected with viruses (MOI = 1) as
indicated. After 16 hours, infected cells were fixed with 3.75% paraformaldehyde and permeabilized
with 0.2% Triton X-100 (VWR International, Dresden, Germany). After blocking with 2% bovine serum
albumin (BSA, AppliChem, Berlin, Germany), polymerized actin of infected cells was detected by
staining with phalloidin-Alexa-Fluor-568 (1:40; Invitrogen) for 20 min. After washing three times,
coverslips were mounted onto glass slides using Vectashield-with 4′,6-diamidino-2-phenylindole
(DAPI; Vector Laboratories, Peterborough, UK). The cells were imaged by immunofluorescence
microscopy (Axio imager M1, Zeiss, Jena, Germany) and pictures were taken with an Axiocam
CCD camera (Zeiss).
2.7. Adhesion Assay
The expression levels of two specific adhesion molecules (very late antigen-4, VLA-4 and
lymphocyte function-associated antigen-1, LFA-1) on the surface of PBMC was analyzed by flow
cytometry. PBMCs were infected with either parental (EHV-1 or EHV-4) or mutant (EHV-1∆US3)
viruses (MOI = 1) or transfected with different expression vectors (pcDNA3, pcDNA3-US3_1
or pcDNA3-US3_4; transfection efficiency was around 40%) using Nucleofector™ (Lonza, Köln,
Germany) [30]. Twenty-four hours after infection or transfection, cells were incubated with anti-VLA-4
or anti-LFA-1 antibodies (5 µg/mL; Abcam, Cambridge, UK) for 1 h at 37 ◦C. Cells were washed
three times with PBS and incubated with anti-rabbit Alexa-Fluor-647 (1:1000; Thermo Fisher Scientific,
Darmstadt, Germany) for 1 h at 37 ◦C. Finally, the cells were washed and the expression level of adhesion
molecules was quantified among the infected cell population (GFP-expressing cells) using flow cytometry.
2.8. Electron Microscopy
ED cells were infected with different viruses (MOI = 1), incubated for 14 h at 37 ◦C, and fixed with
2.5% (v/v) glutaraldehyde and 2% (w/v) paraformaldehyde in 100 mM cacodylate buffer (pH 7.4) for
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30 min at room temperature. Cells were rinsed three times with 100 mM cacodylate buffer, postfixed
and stained for 1 h in 1% osmium tetroxide, rinsed three times with distilled water, stained en bloc with
0.5% uranyl acetate, dehydrated through an ethanol series and finally embedded using EMBed 812
(EMS, Hatfield, PA, USA). Cells were cut en face and 70–90 nm sections were collected. Sections were
counterstained with 4% uranyl acetate followed by lead citrate. All samples were imaged with a Zeiss
EM 900 transmission electron microscope equipped with a wide angle CCD camera (TRS-System,
Moorenweis, Germany).
2.9. Statistical Analysis
Using Prism software (version 5.01, Graphpad, La Jolla, CA, USA), one-way ANOVA, or the
Friedman test for repeated measures were applied to test for significance. All data are given
as arithmetic means and bars show standard deviations (SD). p-values < 0.05 were considered
statistically significant.
3. Results
3.1. Generation of Mutant, Recombinant, and Revertant Viruses
Two-step en passant mutagenesis was used to delete the whole US3 gene from EHV-1
(EHV-1∆US3) and to replace US3_1 with the US3_4 gene (EHV-1US3_4) [26]. Furthermore, EHV-1
with a point mutation in the catalytic active site of pUS3 was engineered by changing the aspartic acid
into alanine (EHV-1D207A). The appropriate revertant viruses, in which the original sequences were
restored, were also generated using the same methodology. The correct deletion of US3_1, the point
mutation and the insertion of US3_4 were analyzed by PCR, by RFLP by using different restriction
enzymes, and by nucleotide sequencing (data not shown).
To determine expression levels of pUS3 by the recombinant viruses, ED cells were infected with
the parental, mutant or recombinant viruses and the cell lysates were analyzed by western blotting.
The pUS3_1 and the pUS3_4 proteins have a predicted molecular weight of approximately 42 kDa [28].
Parental EHV-1, mutant, recombinant, and revertant viruses expressed pUS3_1 or pUS3_4, respectively,
at comparable levels (Figure 1A). As expected, the US3_1-deleted mutant did not express pUS3_1
(Figure 1A). It was clear that EHV-1 anti-US3 could react with EHV-4 pUS3; presumably, due to the
high similarity between these two proteins (98% at the amino acid level). As a control of virus infection,
the expression levels of gB was detected. Proteins with molecular weights of approximately 55 kDa
(corresponding to gB small subunit) [29] were detected in all infected cells (Figure 1B). As a loading
control, heat shock protein 90 α/β (HSP90α/β) (1:1000 dilution; BioLegend, Fell, Germany) was used
(molecular weight: 90 kDa).Viruses 2016, 8, x FOR PEER  6 of 16 
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3.2. Virus Growth Deficit of the EHV-1 US3_1 Mutants Is Rescued by US3_4
Growth kinetics and plaque sizes were determined in three independent experiments using
ED cells. The EHV-1∆US3 and EHV-1D207A viruses showed a significant reduction in growth rates
at most time points after infection when compared to parental EHV-1, revertant or recombinant
EHV-1US3_4 viruses (Figure 2). Similarly, EHV-1∆US3 and EHV-1D207A mutants produced smaller
plaques (only significant in the case of EHV-1D207A) when compared to parental or revertant viruses
(Figure 3). On the other hand, US3_4 recombinant viruses induced bigger plaques; however, they
were not significant compared to parental viruses (Figure 3). It is worth noting that similar results
were obtained with the EHV-1 RacL11 strain [31] (Figure S1). We concluded from the experiments
that growth rates and plaque sizes of EHV-1 were significantly affected by the deletion of US3 or by
mutating the catalytic active site, but that the reduced growth rates were restored by the insertion of
US3_4. This indicated that pUS3 plays an important role in EHV-1 replication and cell-to-cell spread;
however, it does not seem to contribute to the difference in pathogenesis of EHV-1 and EHV-4.
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Figure 2. Growth properties of mutant and recombinant viruses. Confluent equine dermal (ED)
cells were infected with the different viruses as indicated in the figure. Infected cells (A and C) and
supernatant (B and D) were collected separately at different time points post-infection (p.i.; 0, 6, 12, 24
and 30 h) and virus titers were determined. The data presented are means ± standard deviations (SD)
of three independent experiments. Significance levels (p < 0.05) were determined for US3-deleted or
EHV-1D207A viruses when compared to parental, mutant, recombinant and revertant viruses (Friedman
test-Dunn’s multiple comparison test). EHV-1: equine herpesvirus type 1; EHV-1∆US3: EHV-1 where
US3 has been deleted; EHV-1US3_4: EHV-1 where US3_4 replaces US3_1; EHV-1D207A: EHV-1 with
a point mutation in the catalytic active site of pUS3 where aspartic acid was replaced with alanine;
EHV-1A207D: EHV-1 revertant virus where the original aspartic acid was restored.
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3.3. orphological Changes and Actin Stress Fiber Disassembly
Previous studies ith different alphaherpesviruses sho ed that the p S3 protein kinase can
induce cytoskeletal reorganization in different cell types [6,11,32,33]. E cells were infected with
utant or reco binant viruses to deter ine the role of pUS3 in actin microfilament reorganization
and cell morphology. E -1, the US3_4 recombinant, and revertant viruses induced a significant
breakdo n of stress fibers and a striking change of cell morphology (Figure 4A). In contrast,
infection with the US3_1-deleted or EHV-1D207A viruses showed non-significant changes in either cell
orphology or reorganization of the actin cytoskeleton after infection (Figure 4A). For quantitative
analyses, ore than 200 infected cells for each virus (parental, US3_1-deleted, EHV-1D207A,
US3_4-recombinant, and the revertant EHV-1A207D) in three independent experi ents ere inspected
in a blinded fashion, and the percentage of infected cells with changes in actin cytoskeleton were
calculated (Figure 4B,C). The data showed that a mean of 80–90% of cells infected with either the
parental, the US3_4-recombinant, or the revertant viruses exhibited a disassembly of actin stress fibers.
This percent was significantly reduced in cells infected with US3-deleted (60%) and EHV-1D207A (30%)
viruses (p < 0.05; Figure 4B,C). Similar results were also obtained with EHV-1 RacL11strain (Figure S2).
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3.4. EHV-1 US3 Does Not Affect the Expression of Adhesion Molecules on the Surface of PBMC
In our recent study, we showed that EHV-1∆US3 reduced the ability of infected PBMC to adhere
and subsequently transfer virus to EC [16]. We hypothesized that the effect of pUS3 on the actin
cytoskeleton might affect the trafficking and, consequently, the expression of adhesion molecules on
the cell surface, with the result that it may inhibit virus transfer. We, therefore, infected PBMC isolated
from healthy horses with either EHV-1, US3-deleted virus, or EHV-4 and determined expression levels
of adhesion molecules on the surface of PBMC by flow cytometry.
Before investigating the regulation of adhesion molecules on the surface of infected PBMC, the
expression of different adhesion molecules in uninfected PBMC was evaluated using flow cytometry.
We found that two molecules, VLA-4 and LFA-1, were expressed on 20–50% of PBMC (Figure 5A,
left panel). Next, PBMC were either mock-infected or infected with EHV-1 or EHV-4 for 24 h, stained
with anti-VLA-4 or anti-LFA-1, and analyzed by flow cytometry. After 24 hours, the percent of
infected PBMC reached up to 20% for both viruses (Figure 5A, right panel). Cell surface expression of
VLA-4 and LFA-1 was significantly downregulated in EHV-4-infected PBMC (Figure 5B,C), whereas
their expression was either not affected or slightly upregulated in the case of EHV-1-infected cells
(Figure 5B,C). Infection of PBMC with EHV-1∆US3 did not result in any differences of expression
levels of both adhesion molecules (Figure 5D). Furthermore, transfection of PBMC with pcDNA3,
pcDNA3-US3_1 or pcDNA3-US3_4 did not affect the level of expression of the molecules either
(data not shown).Viruses 2016, 8, x FOR PEER  10 of 16 
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Figure 5. EHV-4 downregulates cell surface adhesion molecules on peripheral blood mononuclear cells
(PBMC). (A) surface expression of very late antigen-4 (VLA-4) and lymphocyte fu ction-associat d
antigen-1 (LFA-1) on the surface of mock-i fected PBMC and virus infection (black line: EHV-1; dotted
line: EHV-4) levels of PBMC were determined by flow cytometry. (B and C) Equine PBMC were either
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mock-infected or infected with EHV-4 or EHV-1 and subjected to flow cytometric analysis. Histograms
and bars of VLA-4 (B) and LFA-1 (C) expression after detection with the relevant antibodies are
shown. Viable cells (10,000) were analyzed for each sample. Grey filled: mock-infected cells; dotted
line: mock-infected cells with the relevant antibody; black line: EHV-4-infected cells; grey line:
EHV-1-infected cells. For the bars, the expression level of adhesion molecules (VLA-4 or LFA-1)
was set to 100%. All data represent the mean ± SD of three independent experiments. A significant
downregulation (one-way ANOVA; p < 0.05) of VLA-4 and LFA-1 for EHV-4-infected cells was seen
when compared to mock- or EHV-1-infected cells. (D and E) PBMC were either mock-infected or
infected with EHV-1∆US3 and subjected to flow cytometric analysis. Histograms and bars of VLA-4
(D) and LFA-1 (E) expression are shown. Grey filled: mock-infected cells; dotted line: mock-infected
cells with the relevant antibody; grey line: EHV-1-infected cells; black line: EHV-1∆US3-infected cells.
Data are from one representative experiment out of three. FL1 and FL4: fluorescence detector.
3.5. Accumulation of Enveloped Virions within Perinuclear Vesicles in the Absence of pUS3
ED cells were infected with parental, US3_1-deleted, and US3_4-recombinant viruses for 14 h and
imaged by transmission electron microscopy. In cells infected with parental EHV-1 or recombinant
viruses, numerous extracellular virions released into the extracellular space were readily identifiable
(Figure 6). Non-enveloped nucleocapsids and primarily enveloped virions were also seen in the
perinuclear space. Other stages of virion maturation, including naked nucleocapsids in the cytoplasm
and enveloped virions within cytoplasmic vesicles, were also observed. In contrast, infection with
US3_1-deleted viruses resulted in the presence of a large number of enveloped virions that accumulated
in the perinuclear space within vesicles formed by the inner and outer leaflet of the nuclear membrane
(Figure 7). Furthermore, the extracellular space was clearly devoid of enveloped virions.
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Figure 7. Ultrastructural analysis of ED cells infected with US3-deleted EHV-1. ED cells were infected
for 14 h and analysed by transmission electron microscopy. Cells show accumulation of enveloped
virions in the perinuclear space.
We next conducted quantitative analyses to investigate the differences in distribution of viral
particles in virus-infected cells. Low-magnification electron microscopy (EM) pictures were examined
and virus particles were counted for each virus tested in a blinded fashion. The ata presented in
Table 2 represent the percentag s of total parti l s counted and their distribution as a function of
cellular compartment. In c lls infected with parental and US3_4-recombina t viruses, between 4 and
6.5% of the total particles count d were found within the perinuclear space. However, in c lls infected
with US3-deleted viruses, most of th virus articles (non-envelop d n cl ocapsids and prim ily
enveloped virions) ere trapped in the nucleus either clustered in the perinuclear space (79%) or
elsewhere in the nucleus (11%). As described earlier, quantification revealed that more than 93% of
the enveloped virus particles were commonly observed on the surface of cells infected with parental
or US3_4-recombinant viruses, while in cells infected with US3-deleted viruses, the frequency of
enveloped extracellular particles was reduced to only 10%.
Table 2. Virus particles observed in infected eq ine dermal (ED) cells by electron microscopy (EM).
Virus
% of virus particles
Total Counted
(Particles/Cells)Nucleus Extracellular and
Cytoplasmic VesiclesPerinuclear area Intranuclear
EHV-1 6.5 0 93.5 246/10
EHV-1∆US3 79 11 10 203/12
EHV-1US3_4 4 0 96 417/12
EHV-1: equine herpesvirus type 1.
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4. Discussion
The US3 serine-threonine protein kinase is conserved among all alphaherpesviruses including
EHV-1 [6]. The aim of our study was to assess the roles of pUS3 during EHV-1 infection and to relate
our findings to the known functions of pUS3 in other alphaherpesviruses. Furthermore, in our attempt
to unravel the functions of viral proteins to understand the striking difference between EHV-1 and
EHV-4 regarding replication in vitro and in vivo, we sought to study the functions of pUS3_1 and
pUS3-4. We mostly relied on the generation and characterization of mutant viruses where US3 was
completely deleted or targeted with point mutations.
Here we show that, like for other alphaherpesviruses, pUS3 is not essential for viral replication.
However, plaque size assays and growth kinetics showed that the deletion of US3 had a modest but
significant effect on virus replication and cell-to-cell spread. This loss-of-function was restored after
inserting US3_4 into EHV-1 genome, indicating that the US3_4 protein can efficiently compensate for
the function of EHV-1 pUS3 in an EHV-1 background. Similar results on the effect of pUS3 on virus
replication were previously obtained after deletion of US3 in HSV-1, BHV-1, PRV, and MDV [18–20,34].
Similarly, targeting the catalytic active site of EHV-1 pUS3 significantly affected virus replication and
cell-to-cell spread as shown before in the case of BHV-5, PRV and HSV-2 [33,35,36]. One possible
explanation for the stark effect seen is the involvement of the pUS3 protein kinase in the release of
primarily enveloped viruses from the nucleus, which leads to the accumulation of virions between the
inner and outer nuclear membrane in the absence of the kinase and may consequently result in a less
efficient infection of neighboring cells [19]. The EM data presented for EHV-1 and US3 mutant viruses
shows that US3 is important for the process of virion de-envelopment at the outer leaflet of the nuclear
membrane. However, this important step in virion morphogenesis was restored in the recombinant
EHV-1 expressing US3_4.
The US3-encoded protein is a serine/threonine kinase that is known to phosphorylate both viral
and cellular proteins, but its targets in the case of EHV-1 are still unknown. pUS3 kinase domains
are conserved in different alphaherpesviruses including EHV-1 [32]. Previous reports have shown
that HSV-1 pUS3 kinase is responsible for building a functional complex between pUL34 and pUL31,
which is essential for primary envelopment at the inner leaflet of the nuclear membrane of newly
formed nucleocapsids [37,38]. However, in the case of PRV, pUS3 appears to also be involved in
the de-envelopment of perinuclear virions by fusion of the primary envelope, which mainly or even
exclusively consists of pUL34, with the outer leaflet of the nuclear membrane. Of note, this process is
probably not dependent on phosphorylation of pUL34 by pUS3 [18]. Measuring the phosphorylation
status of EHV-1 pUL34 and pUL31 in the presence or absence of pUS3 during future experiments will
be crucial for determining their role in virus egress from the nucleus.
Besides its role in the de-envelopment process of virions, we demonstrated that the kinase activity
of EHV-1 pUS3 also contributes to reorganization of actin, which is deemed important for efficient
cell-to-cell spread. As reported for BHV-1, BHV-5, PRV and MDV [20,32,33,39], our data showed
that EHV-1 pUS3 induces cytoskeletal modifications leading to breakdown of actin stress fibers.
After replacing US3_1 with US3_4, it was evident that the virus-inherent and pUS3-dependent ability
to reorganize stress fibers was restored and was indistinguishable from parental virus. The requirement
for cytoskeletal modifications has been shown to be different amongst the alphaherpesviruses. While in
PRV pUS3 kinase activity seems essential for actin rearrangement, MDV pUS3 does not require kinase
activity for the same phenotype [11,20]. In contrast, BHV-5 seems to have kinase-dependent and
-independent actin modification functions [33].
Viruses modulate the actin cytoskeleton at almost every step of their replication cycle, starting
from entry and ending in egress in order to facilitate spread. One important step during EHV-1
pathogenesis is viral transfer from infected PBMC to endothelial cells, a process that might depend on
the upregulation of cellular adhesion molecules in response to virus infection. Recently, we reported
that deletion of US3 reduced the ability of EHV-1-infected PBMC to tether and roll over EC and resulted
in a significant reduction of virus transfer from PBMC to EC [16]. We speculated that pUS3-mediated
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actin rearrangement might be influencing adhesion molecule expression on the surface of infected
PBMC [6,40], thereby affecting PBMC-adherence and virus transfer. Our current data show that
EHV-4 was able to downregulate adhesion molecules on the surface of infected PBMC, which partly
explains the inability of EHV-4-infected PBMC to adhere and subsequently transfer the virus to EC.
EHV-1, on the other hand, either did not affect or slightly upregulated adhesion molecules on infected
PBMC. Similarly, the expression level of adhesion molecules was not affected after infecting PBMC
with EHV-1∆US3, indicating that pUS3-mediated actin reorganization did not affect the expression
of the tested adhesion molecules (VLA-4 and LFA-1) on the cell surface. Not only VLA-4 and LFA-1,
but also several other adhesion molecules were shown to have a role in mediating firm adhesion of
activated PBMC to EC [41–46]. We attempted to determine the expression levels of other molecules;
however, either the levels of expression were very low or the available commercial antibodies were not
reactive with the equine molecules. The possibility that pUS3 affects the expression of other adhesion
molecules cannot be excluded. Alternatively, pUS3-induced changes in the actin skeleton may affect
the formation and stabilization of clusters of adhesion molecules at the cell surface, thereby altering
the adhesive properties of the cell without changing the actual number of adhesion molecules on the
cell [47]. Furthermore, other pUS3 activities such as the anti-apoptotic effects may also protect PBMC
from clearance before EHV-1 is able to transfer to the EC.
5. Conclusions
In conclusion, our report shows that EHV-1 pUS3 is necessary for egress from the nucleus.
Furthermore, the serine/threonine protein kinase activity of EHV-1 pUS3 plays an important role in
actin cytoskeleton rearrangement. Further investigation of pUS3 kinase activity in infected cells will
be conducted to understand the mechanism of its observed role in the infection cycle.
Supplementary Materials: The following are available online at www.mdpi.com/1999-4915/8/9/275/s1,
Figure S1: Characterization of RacL11∆US3 virus; Figure S2: Disassembly of actin cytoskeleton in ED cells
infected with RacL strain.
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